Dose to the bladder neck, external urethral sphincter2, and neurovascular bundles may impact complications related to urinary toxicity and sexual function.
MRI-based plans provide a more accurate prediction for post-op dosimetry than US-based planning.
“How do we implement MRI-guided Brachytherapy?”
“How do we account for orientation differences and register the MRI to our ultrasound?”
“How do we incorporate MRI without extending OR time?”
Provides seamless MRI to ultrasound registration.
Guides you to eliminate misalignments and deformation errors during ultrasound acquisition.
Full treatment planning platform for MR or US-based planning with the same platform and tools as MIM Maestro®.
Using MRI provides the ability to boost dose to the MRI-visible lesion and enables more conformal dosimetry, resulting in improved cancer control with fewer complications.
Enables localization and real-time QA of the lesion using registrations.
Establishes a relationship between MRI-visible lesions and catheter placements.
Provides a reproducible process with automated tools for guidance during procedures.
MIM Symphony is a general purpose Brachytherapy platform. While prostate is an important treatment site, MIM supports a variety of treatments either directly or with our strategic partners.